(Q47230945)

12 January 2018

title

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma (English)

1 reference

12 January 2018

esophageal squamous cell carcinoma

main subject

1 reference

Tong Sun

1

1 reference

12 January 2018

Xiaoping Miao

2

1 reference

12 January 2018

Xuemei Zhang

3

1 reference

12 January 2018

Wen Tan

4

1 reference

12 January 2018

Ping Xiong

5

1 reference

12 January 2018

Dongxin Lin

6

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

12 January 2018

Journal of the National Cancer Institute

published in

1 reference

12 January 2018

volume

96

1 reference

12 January 2018

issue

13

1 reference

12 January 2018

page(s)

1030-1036

1 reference

12 January 2018

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

1 reference

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

The biological role of the Fas/FasL system during tumor formation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Defining CD95 as a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

CD95's deadly mission in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Population attributable risks of esophageal and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Investigation of the -1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH187

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH187

1 reference

12 January 2018

1 reference

12 January 2018